{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:55:51Z","timestamp":1791219351165,"version":"4.1.0"},"reference-count":123,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2017,11,22]],"date-time":"2017-11-22T00:00:00Z","timestamp":1511308800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100001021","name":"Damon Runyon Cancer Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001021","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["K12CA090354"],"award-info":[{"award-number":["K12CA090354"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009634","name":"Susan G. Komen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009634","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer"],"published-print":{"date-parts":[[2018,1]]},"abstract":"<jats:p>Leptomeningeal metastasis is an uncommon and typically late complication of cancer with a poor prognosis and limited treatment options. Diagnosis is often challenging, with nonspecific presenting symptoms ranging from headache and confusion to focal neurologic deficits, such as cranial nerve palsies. Standard diagnostic evaluation involves a neurologic examination, magnetic resonance imaging of the brain and spine with gadolinium, and cytologic evaluation of the cerebral spinal fluid. Therapy entails a multimodal approach focused on palliation with surgery, radiation, and\/or chemotherapy, which may be administered systemically or directly into the cerebral spinal fluid. Limited trial data exist to guide treatment, and current regimens are based primarily on expert opinion. Although newer targeted and immunotherapeutic agents are under investigation and have shown promise, an improved understanding of the biology of leptomeningeal metastasis and treatment resistance as well as additional randomized controlled studies are needed to guide the optimal treatment of this devastating disease. <jats:bold><jats:italic>Cancer<\/jats:italic> 2018;124:21\u201035.<\/jats:bold> \u00a9 <jats:italic>2017 American Cancer Society<\/jats:italic>.<\/jats:p>","DOI":"10.1002\/cncr.30911","type":"journal-article","created":{"date-parts":[[2017,11,22]],"date-time":"2017-11-22T07:32:57Z","timestamp":1511335977000},"page":"21-35","source":"Crossref","is-referenced-by-count":230,"title":["Leptomeningeal metastasis from systemic cancer: Review and update on management"],"prefix":"10.1002","volume":"124","author":[{"given":"Nancy","family":"Wang","sequence":"first","affiliation":[{"name":"Division of Neuro\u2010Oncology, Massachusetts General Hospital, Harvard Medical School Boston Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3519-7985","authenticated-orcid":false,"given":"Mia S.","family":"Bertalan","sequence":"additional","affiliation":[{"name":"Division of Neuro\u2010Oncology, Massachusetts General Hospital, Harvard Medical School Boston Massachusetts"},{"name":"Division of Hematology and Oncology, Massachusetts General Hospital, Harvard Medical School Boston Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscilla K.","family":"Brastianos","sequence":"additional","affiliation":[{"name":"Division of Neuro\u2010Oncology, Massachusetts General Hospital, Harvard Medical School Boston Massachusetts"},{"name":"Division of Hematology and Oncology, Massachusetts General Hospital, Harvard Medical School Boston Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,11,22]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(10)70034-6"},{"key":"e_1_2_1_3_1","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/BF02214196","article-title":"Zur Entwickelung des Epithelioms (Cholesteatoms) der Pia und der Lunge","volume":"49","author":"Eberth CJ","year":"1869","journal-title":"Virchows Arch A Pathol Anat."},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.02.025"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.56.653.149"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1974.00490320010002"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19831215)52:12<2349::AID-CNCR2820521231>3.0.CO;2-B"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(81)90254-0"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197808)42:2<660::AID-CNCR2820420237>3.0.CO;2-E"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2012.163"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0733-8619(02)00032-4"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nec.2010.08.007"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1001\/archneurol.2010.18"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2008.04.004"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1996.00550070064013"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19820215)49:4<759::AID-CNCR2820490427>3.0.CO;2-7"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181dc1a69"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-008-9758-3"},{"key":"e_1_2_1_19_1","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1212\/01.CON.0000413665.80915.c4","article-title":"CNS infections in patients with cancer","volume":"18","author":"Pruitt AA","year":"2012","journal-title":"Continuum (Minneap Minn)"},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9260(99)91181-9"},{"key":"e_1_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/s004150050459"},{"issue":"2","key":"e_1_2_1_22_1","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1053\/j.seminoncol.2009.05.005","article-title":"Diagnostic tools for neoplastic meningitis: detecting disease, identifying patient risk, and determining benefit of treatment","volume":"36","author":"Chamberlain MC","year":"2009","journal-title":"Semin Oncol"},{"key":"e_1_2_1_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410380111"},{"issue":"4","key":"e_1_2_1_24_1","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/annonc\/mdh941","article-title":"The diagnostic and therapeutic management of leptomeningeal carcinomatosis","volume":"15","author":"Pavlidis N","year":"2004","journal-title":"Ann Oncol"},{"key":"e_1_2_1_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19980215)82:4<733::AID-CNCR17>3.0.CO;2-Z"},{"key":"e_1_2_1_26_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000261909.28915.83"},{"key":"e_1_2_1_27_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1005956925637"},{"key":"e_1_2_1_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410080609"},{"key":"e_1_2_1_29_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.66.6487"},{"key":"e_1_2_1_30_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.13397"},{"key":"e_1_2_1_31_1","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2014.235457"},{"key":"e_1_2_1_32_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1987.5.10.1655"},{"key":"e_1_2_1_33_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1993.11.3.561"},{"key":"e_1_2_1_34_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1999.17.10.3110"},{"key":"e_1_2_1_35_1","first-page":"3394","article-title":"A randomized controlled trial comparing intrathecal sustained\u2010release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors","volume":"5","author":"Glantz MJ","year":"1999","journal-title":"Clin Cancer Res."},{"key":"e_1_2_1_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2004.08.012"},{"key":"e_1_2_1_37_1","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1200\/jco.2006.24.18_suppl.1528","article-title":"A randomized phase III\/IV study to determine benefit and safety of cytarabine liposome injection for treatment of neoplastic meningitis","volume":"24","author":"Shapiro WR","year":"2006","journal-title":"J Clin Oncol."},{"key":"e_1_2_1_38_1","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/nou089"},{"key":"e_1_2_1_39_1","first-page":"484","article-title":"Leptomeningeal metastases: a RANO proposal for response criteria","volume":"19","author":"Chamberlain M","year":"2017","journal-title":"Neuro Oncol"},{"key":"e_1_2_1_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2015.12.021"},{"key":"e_1_2_1_41_1","doi-asserted-by":"crossref","first-page":"3394","DOI":"10.1001\/archneurol.2008.506","article-title":"Neoplastic meningitis\u2010related prognostic significance of the Karnofsky performance status","volume":"66","author":"Chamberlain MC","year":"2009","journal-title":"Arch Neurol"},{"key":"e_1_2_1_42_1","volume-title":"Central Nervous System Cancers","author":"National Comprehensive Cancer Network (NCCN)","year":"2016"},{"key":"e_1_2_1_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2004.05.008"},{"key":"e_1_2_1_44_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-010-0831-x"},{"key":"e_1_2_1_45_1","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1994.00540170033013"},{"key":"e_1_2_1_46_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1005803918194"},{"key":"e_1_2_1_47_1","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1159\/000322661","article-title":"Clinical recommendations of DEGRO and AGO on preferred standard palliative radiotherapy of bone and cerebral metastases, metastatic spinal cord compression, and leptomeningeal carcinomatosis in breast cancer","volume":"5","author":"Souchon R","year":"2010","journal-title":"Breast Care"},{"key":"e_1_2_1_48_1","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.55.4.506"},{"key":"e_1_2_1_49_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.30214"},{"key":"e_1_2_1_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)61299-X"},{"key":"e_1_2_1_51_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-003-0083-x"},{"key":"e_1_2_1_52_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19980501)82:9<1764::AID-CNCR24>3.0.CO;2-1"},{"key":"e_1_2_1_53_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197310112891503"},{"key":"e_1_2_1_54_1","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e3182398e4f"},{"key":"e_1_2_1_55_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00066-011-0025-8"},{"key":"e_1_2_1_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.prro.2017.05.002"},{"key":"e_1_2_1_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2014.08.004"},{"key":"e_1_2_1_58_1","doi-asserted-by":"publisher","DOI":"10.3171\/jns.1997.87.5.0694"},{"key":"e_1_2_1_59_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2008-0138"},{"key":"e_1_2_1_60_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0030-1255220"},{"issue":"1","key":"e_1_2_1_61_1","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1227\/00006123-198801000-00016","article-title":"Antibiotic therapy for infected Ommaya reservoir systems","volume":"22","author":"Siegal T","year":"1988","journal-title":"Neurosurgery"},{"key":"e_1_2_1_62_1","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jinf.2013.12.002","article-title":"Ommaya reservoir\u2010related infections: clinical manifestations and treatment outcomes","volume":"68","author":"Szvalb AD","year":"2014","journal-title":"J Infect"},{"key":"e_1_2_1_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(82)90404-1"},{"key":"e_1_2_1_64_1","doi-asserted-by":"publisher","DOI":"10.3171\/2011.5.JNS101768"},{"key":"e_1_2_1_65_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1998.16.4.1561"},{"key":"e_1_2_1_66_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-005-9044-6"},{"key":"e_1_2_1_67_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1984.2.5.365"},{"key":"e_1_2_1_68_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19930715)72:2<439::AID-CNCR2820720220>3.0.CO;2-4"},{"key":"e_1_2_1_69_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-007-9409-0"},{"key":"e_1_2_1_70_1","doi-asserted-by":"publisher","DOI":"10.1023\/B:NEON.0000003752.89814.ca"},{"key":"e_1_2_1_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2008.04.015"},{"key":"e_1_2_1_72_1","doi-asserted-by":"publisher","DOI":"10.1215\/S1152851703000334"},{"key":"e_1_2_1_73_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-015-2259-1"},{"key":"e_1_2_1_74_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-012-0879-3"},{"key":"e_1_2_1_75_1","doi-asserted-by":"publisher","DOI":"10.1016\/0277-5379(89)90033-3"},{"key":"e_1_2_1_76_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-007-9340-4"},{"key":"e_1_2_1_77_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.44.8.1463"},{"key":"e_1_2_1_78_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1005999228846"},{"key":"e_1_2_1_79_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.46.5773"},{"key":"e_1_2_1_80_1","doi-asserted-by":"publisher","DOI":"10.1186\/1752-1947-6-131"},{"key":"e_1_2_1_81_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)60898-4"},{"key":"e_1_2_1_82_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1412690"},{"key":"e_1_2_1_83_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)30122-X"},{"key":"e_1_2_1_84_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.12.149"},{"key":"e_1_2_1_85_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-011-1417-2"},{"key":"e_1_2_1_86_1","first-page":"1373","article-title":"Application of intrathecal trastuzumab (Herceptin) for treatment of meningeal carcinomatosis in HER2\u2010overexpressing metastatic breast cancer","volume":"15","author":"Stemmler HJ","year":"2006","journal-title":"Oncol Rep"},{"key":"e_1_2_1_87_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-013-2525-y"},{"key":"e_1_2_1_88_1","first-page":"154674","article-title":"Intrathecal trastuzumab treatment of the neoplastic meningitis due to breast cancer: a case report and review of the literature [serial online]","volume":"2013","author":"Dumitrescu C","year":"2013","journal-title":"Case Rep Oncol Med"},{"key":"e_1_2_1_89_1","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s40425-015-0084-y","article-title":"Intrathecal trastuzumab: immunotherapy improves the prognosis of leptomeningeal metastases in HER\u20102\u2009+\u2009breast cancer patient [serial online]","volume":"3","author":"Lu NT","year":"2015","journal-title":"J Immunother Cancer"},{"issue":"15","key":"e_1_2_1_90_1","article-title":"Intra\u2010CSF trastuzumab in patients with neoplastic meningitis from breast cancer or primary brain tumors [abstract]","volume":"27","author":"Allison DL","year":"2009","journal-title":"J Clin Oncol"},{"issue":"5","key":"e_1_2_1_91_1","doi-asserted-by":"crossref","first-page":"v19","DOI":"10.1093\/neuonc\/nou237.46","article-title":"AT\u201047 phase I trial of intrathecal trastuzumab in her2 positive leptomeningeal metastases [abstract]","volume":"16","author":"Raizer J","year":"2014","journal-title":"Neuro Oncol."},{"key":"e_1_2_1_92_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(12)70432-1"},{"key":"e_1_2_1_93_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-012-0990-5"},{"key":"e_1_2_1_94_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-10-1934"},{"key":"e_1_2_1_95_1","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/nor121"},{"key":"e_1_2_1_96_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-015-2759-y"},{"key":"e_1_2_1_97_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.21.0963"},{"key":"e_1_2_1_98_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2008.10.016"},{"key":"e_1_2_1_99_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-011-1555-6"},{"key":"e_1_2_1_100_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-010-0128-6"},{"key":"e_1_2_1_101_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2012.12.024"},{"key":"e_1_2_1_102_1","doi-asserted-by":"publisher","DOI":"10.1111\/1759-7714.12049"},{"key":"e_1_2_1_103_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.resinv.2015.07.001"},{"key":"e_1_2_1_104_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.06.6126"},{"key":"e_1_2_1_105_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.2886"},{"key":"e_1_2_1_106_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2011.11.022"},{"key":"e_1_2_1_107_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2012.03.002"},{"key":"e_1_2_1_108_1","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0000000000000380"},{"key":"e_1_2_1_109_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajco.12643"},{"key":"e_1_2_1_110_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2014.06.002"},{"key":"e_1_2_1_111_1","article-title":"Osimertinib activity in patients (pts) with leptomeningeal (LM) disease from non\u2010small cell lung cancer (NSCLC): updated results from BLOOM, a phase I study [abstract]","volume":"34","author":"Yang JCH","year":"2016","journal-title":"J Clin Oncol"},{"key":"e_1_2_1_112_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdn679"},{"key":"e_1_2_1_113_1","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e3181a52359"},{"key":"e_1_2_1_114_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1006448"},{"key":"e_1_2_1_115_1","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0000000000000455"},{"key":"e_1_2_1_116_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2014-0309"},{"key":"e_1_2_1_117_1","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0000000000000174"},{"key":"e_1_2_1_118_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000160396.69050.DC"},{"key":"e_1_2_1_119_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1005948722912"},{"key":"e_1_2_1_120_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.10547"},{"key":"e_1_2_1_121_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-012-6488-4"},{"key":"e_1_2_1_122_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1005996606073"},{"key":"e_1_2_1_123_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01052668"},{"key":"e_1_2_1_124_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.11.1807"}],"container-title":["Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fcncr.30911","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cncr.30911","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T17:19:10Z","timestamp":1760289550000},"score":1,"resource":{"primary":{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/10.1002\/cncr.30911"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,22]]},"references-count":123,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["10.1002\/cncr.30911"],"URL":"https:\/\/doi.org\/10.1002\/cncr.30911","archive":["Portico"],"relation":{},"ISSN":["0008-543X","1097-0142"],"issn-type":[{"value":"0008-543X","type":"print"},{"value":"1097-0142","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,22]]}}}